Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bifeprunox in the Treatment of Schizophrenia

This study has been completed.
Information provided by:
Solvay Pharmaceuticals Identifier:
First received: September 11, 2005
Last updated: January 15, 2015
Last verified: January 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2006
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)